Fibrin-specific plasminogen activator TNKase (tenecteplase) is the first stroke medicine approved by the FDA in nearly 30 years, joining Roche/Genentech's Activase (alteplase), which is the only ...

Alteplase is also sold by Boehringer in the UK under the Actilyse brand. According to NICE, Metalyse costs less than alteplase, so could save the NHS millions of pounds when used as a stroke ...